Assignee
CureVac SE
DE62 patents
Top patents by PatentIndex Score
US11739125B2Aug 29, 2023
Respiratory syncytial virus (RSV) vaccine
CureVac SE10 citations94
US11596686B2Mar 7, 2023
Coronavirus vaccine
CureVac SE16 citations94
US11576966B2Feb 14, 2023
Coronavirus vaccine
CureVac SE16 citations94
US11786590B2Oct 17, 2023
Rotavirus vaccines
CureVac SE5 citations86
US11596699B2Mar 7, 2023
RNA encoding an antibody
CureVac SE11 citations86
US11559570B2Jan 24, 2023
Prime-boost regimens involving administration of at least one mRNA construct
CureVac SE8 citations86
US11965000B2Apr 23, 2024
Respiratory syncytial virus (RSV) vaccine
CureVac SE7 citations85
US11761009B2Sep 19, 2023
Artificial nucleic acid molecules for improved protein expression
CureVac SE5 citations85
US12168050B2Dec 17, 2024
Compositions comprising a norovirus nucleic acid and methods of use thereof
CureVac SE4 citations84
US11602557B2Mar 14, 2023
Bunyavirales vaccine
CureVac SE11 citations84
US11524066B2Dec 13, 2022
Henipavirus vaccine
CureVac SE8 citations84
US11723967B2Aug 15, 2023
Zika virus vaccine
CureVac SE7 citations83
US11692002B2Jul 4, 2023
RNA sequence adaptation
CureVac SE7 citations82
US11608513B2Mar 21, 2023
Method for adding cap structures to RNA using immobilized enzymes
CureVac SE7 citations82
US11525158B2Dec 13, 2022
Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNA
CureVac SE8 citations82
US11918643B2Mar 5, 2024
RNA vaccine against SARS-CoV-2 variants
CureVac SE6 citations81
US11739335B2Aug 29, 2023
Nucleic acids encoding CRISPR-associated proteins and uses thereof
CureVac SE7 citations80
US11542490B2Jan 3, 2023
RNAs for wound healing
CureVac SE8 citations77
US12460204B2Nov 4, 2025
Artificial nucleic acid molecules for improved protein or peptide expression
CureVac SE1 citations75
US12318444B2Jun 3, 2025
Rotavirus vaccines
CureVac SE1 citations75
US12442005B2Oct 14, 2025
Artificial nucleic acid molecules for improved protein expression
CureVac SE1 citations74
US12318486B2Jun 3, 2025
Dry powder composition comprising long-chain RNA
CureVac SE3 citations74
US12194089B2Jan 14, 2025
Coronavirus vaccine
CureVac SE1 citations74
US12138348B2Nov 12, 2024
Dry powder composition comprising long-chain RNA
CureVac SE3 citations74
US11690910B2Jul 4, 2023
Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen
CureVac SE6 citations74
US12109275B2Oct 8, 2024
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CureVac SE1 citations73
US11697816B2Jul 11, 2023
Artificial nucleic acid molecules
CureVac SE5 citations73
US11964012B2Apr 23, 2024
Coronavirus vaccine
CureVac SE2 citations72
US11872280B2Jan 16, 2024
RNA vaccine against SARS-CoV-2 variants
CureVac SE5 citations70
US12533422B2Jan 27, 2026
Modified RNA with decreased immunostimulatory properties
CureVac SE0 citations63
US12201680B2Jan 21, 2025
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CureVac SE0 citations63
US12447209B2Oct 21, 2025
Combination of vaccination and inhibition of the PD-1 pathway
CureVac SE0 citations62
US12390523B2Aug 19, 2025
Coronavirus vaccine
CureVac SE0 citations62
US12390520B2Aug 19, 2025
Vaccination in newborns and infants
CureVac SE0 citations62
US12240873B2Mar 4, 2025
Respiratory syncytial virus (RSV) vaccine
CureVac SE0 citations62
US12227549B2Feb 18, 2025
RNA encoding a therapeutic protein
CureVac SE0 citations62
US12139513B2Nov 12, 2024
Respiratory syncytial virus (RSV) vaccine
CureVac SE0 citations62
US12083190B2Sep 10, 2024
Rabies vaccine
CureVac SE0 citations62
US12036277B2Jul 16, 2024
Vaccination with mRNA-coded antigens
CureVac SE0 citations62
US11975064B2May 7, 2024
Vaccination with mRNA-coded antigens
CureVac SE0 citations62
US11964011B2Apr 23, 2024
Coronavirus vaccine
CureVac SE0 citations62
US11865084B2Jan 9, 2024
MERS coronavirus vaccine
CureVac SE0 citations62
US12527856B2Jan 20, 2026
Artificial RNA molecules encoding a norovirus antigen and uses thereof
CureVac SE0 citations61
US12514918B2Jan 6, 2026
Nucleic acid molecules and uses thereof
CureVac SE0 citations61
US12397048B2Aug 26, 2025
Bunyavirales vaccine
CureVac SE0 citations61
US12258567B2Mar 25, 2025
Artificial nucleic acid molecules
CureVac SE0 citations61
US12201682B2Jan 21, 2025
Henipavirus vaccine
CureVac SE0 citations61
US12161711B2Dec 10, 2024
Lassa virus vaccine
CureVac SE1 citations61
US12048738B2Jul 30, 2024
Composition for treating prostate cancer (PCa)
CureVac SE0 citations61
US12496335B2Dec 16, 2025
Zika virus vaccine
CureVac SE0 citations60
Showing the top 50 of 62 patents by PatentIndex Score.